These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15793636)

  • 1. Aberrant methylation of HLTF, SOCS-1, and CDH13 genes is shown in colorectal cancers without lymph node metastasis.
    Hibi K; Kodera Y; Ito K; Akiyama S; Nakao A
    Dis Colon Rectum; 2005 Jun; 48(6):1282-6. PubMed ID: 15793636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node metastasis is infrequent in patients with highly-methylated colorectal cancer.
    Hibi K; Nakao A
    Anticancer Res; 2006; 26(1A):55-8. PubMed ID: 16475679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly-methylated colorectal cancers show poorly-differentiated phenotype.
    Hibi K; Nakao A
    Anticancer Res; 2006; 26(6B):4263-6. PubMed ID: 17201142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma.
    Fukuoka T; Hibi K; Nakao A
    Anticancer Res; 2006; 26(5A):3333-5. PubMed ID: 17094449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
    Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF
    Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients.
    Fujitake S; Hibi K; Okochi O; Kodera Y; Ito K; Akiyama S; Nakao A
    J Gastroenterol; 2004; 39(2):120-4. PubMed ID: 15074307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma.
    Oshimo Y; Kuraoka K; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
    Int J Cancer; 2004 Dec; 112(6):1003-9. PubMed ID: 15386345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation pattern of HLTF gene in digestive tract cancers.
    Hibi K; Nakayama H; Kanyama Y; Kodera Y; Ito K; Akiyama S; Nakao A
    Int J Cancer; 2003 Apr; 104(4):433-6. PubMed ID: 12584739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
    Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
    Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX3 promoter region is specifically methylated in poorly-differentiated colorectal cancer.
    Imamura Y; Hibi K; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
    Anticancer Res; 2005; 25(4):2627-30. PubMed ID: 16080503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
    Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE
    Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition.
    Weber A; Hengge UR; Bardenheuer W; Tischoff I; Sommerer F; Markwarth A; Dietz A; Wittekind C; Tannapfel A
    Oncogene; 2005 Oct; 24(44):6699-708. PubMed ID: 16007169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer.
    Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
    Br J Cancer; 2004 Mar; 90(5):1030-3. PubMed ID: 14997203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional control of impaired Th1 responses in patent lymphatic filariasis by T-box expressed in T cells and suppressor of cytokine signaling genes.
    Babu S; Kumaraswami V; Nutman TB
    Infect Immun; 2005 Jun; 73(6):3394-401. PubMed ID: 15908366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
    Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
    J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer.
    Leung WK; To KF; Man EP; Chan MW; Bai AH; Hui AJ; Chan FK; Sung JJ
    Am J Gastroenterol; 2005 Oct; 100(10):2274-9. PubMed ID: 16181380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
    Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A
    Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDH13 and FLBN3 gene methylation are associated with poor prognosis in colorectal cancer.
    Wang Z; Yuan X; Jiao N; Zhu H; Zhang Y; Tong J
    Pathol Oncol Res; 2012 Apr; 18(2):263-70. PubMed ID: 21796503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of methylated free circulating DNA in colorectal cancer.
    Philipp AB; Stieber P; Nagel D; Neumann J; Spelsberg F; Jung A; Lamerz R; Herbst A; Kolligs FT
    Int J Cancer; 2012 Nov; 131(10):2308-19. PubMed ID: 22362391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly methylated genes in colorectal neoplasia: implications for screening.
    Zou H; Harrington JJ; Shire AM; Rego RL; Wang L; Campbell ME; Oberg AL; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2686-96. PubMed ID: 18086775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.